Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Ovzon: Decent Q2, important Ovzon-3 order - ABG

OVZONThird party research19.08.2024, 13.52

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Solid sequential improvements, first Ovzon 3 order
'24e-'26e sales down 18-7% on softer orders than expected
We expect positive EBITDA in H2e


Weaker Q2 than expected, but solid progress over Q1

After a slow start to the year, particularly in the US, Q2 showed solid progress, with sequential growth in satellite services of 58%, to SEK 57m, and a significant slowdown in opex. Even so, total sales of SEK 67m were below ABGSCe of SEK 72m, mainly due to lower than expected terminal sales. The EU, which is an increasingly important market for Ovzon, had a solid quarter, while sales in the US improved to SEK 30m (vs. SEK 13m in Q1), although this remains well below historical levels of ~SEK 50m. More importantly, Ovzon signed its first Ovzon 3-related order after the end of the quarter: a 12-month USD 6.2m order from the US DoD (link). In addition to the important strategic value, the deal replaces the previous 8-month contract with the DoD and represents a 33% upgrade, suggesting that Ovzon is able to charge premium prices for the enhanced service. The satellite's capacity is limited, so we expect prices to continue to increase gradually as the satellite's capacity is further utilised.